Infectious actinobacillus pleuropneumoniae and application thereof
A technology of pleuropneumonia and actinobacillus, which is applied in the direction of bacteria, antibacterial drugs, veterinary vaccines, etc., can solve the problems of lack of cross-immune protection and achieve good protection effect, strong pathogenicity, and good immunogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1, Isolation and identification of infectious Actinobacillus pleuropneumoniae
[0022] 1.1 Disease data collection
[0023] The disease material came from a 5-month-old fattening pig that died of severe pneumonia and dyspnea in a large pig farm in Ruzhou City, Henan Province in November 2016.
[0024] 1.2 Preparation of medium
[0025] TSB liquid medium: Dissolve 30 g of TSB broth powder (Tryptic Soy broth, tryptone soybean broth) in 1000 mL of ultrapure water, sterilize at 115 °C for 15 min, add 50 mL of fetal bovine serum, sterile 1% NAD (Nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide, coenzyme Ⅰ) 1mL.
[0026] TSA solid medium: Dissolve 40 g of TSA agar powder (Tryptic Soy Agar, tryptone soybean agar) in 1000 mL of ultrapure water, sterilize at 115 ° C for 15 min, add 50 mL of fetal bovine serum, sterile 1% NAD (add as needed ) 1 mL; store at 4°C for future use.
[0027] 1.3 Isolation and culture of bacteria
[0028] Aseptically col...
Embodiment 2
[0050] Embodiment 2, the preparation of vaccine, safety and efficacy test
[0051] 2.1 Preparation of vaccine
[0052] Inoculate the infectious Actinobacillus pleuropneumoniae strain HNAPP1 into the TSB liquid medium, culture it in a shaker at 37°C, collect the culture after 18 hours, measure the concentration, and adjust the number of bacteria in the culture to 2×10 9 CFU / mL, add formaldehyde to a final concentration of 0.2%, inactivate at 37°C for 12h. The inactivated culture is added with aluminum hydroxide adjuvant at a volume ratio of 1:1, and mixed to prepare an inactivated vaccine of infectious Actinobacillus pleuropneumoniae.
[0053] 2.2 Vaccine safety test:
[0054] Ten healthy nursery pigs aged 2 months were selected and divided into 2 groups with 5 pigs in each group. Vaccine group: intramuscular injection of 4 mL of this vaccine in the neck; control group: intramuscular injection of 4 mL of sterilized normal saline in the neck. The body temperature of the anim...
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com